Cipla has pledged support to ‘Terra Carta’, a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales’ Sustainable Markets Initiative that was launched in Davos in 2020, with founding partners such as Bank of America, HSBC, BP and NatWest among others.
Since its launch in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations. Cipla is one of the five Indian companies and the only Indian pharmaceutical company to participate. While continuing to achieve its own environmental, social and governance (ESG) goals, Cipla would also have the opportunity to drive ESG discourse within the sector and at a regional level. At the same time, the initative would allow participating organizations to cross-learn from one another.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1808.20 |
| Dr. Reddys Lab | 1322.95 |
| Cipla | 1309.90 |
| Zydus Lifesciences | 891.65 |
| Lupin | 2303.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: